PET/CT And The Response To Immunotherapy In Lung Cancer.
CONCLUSIONS: The utility of FDG PET/CT for patients with lung cancer undergoing immunotherapies, is still preliminary and not well addresses. New agents for PET are promising, but large clinical trials are mandatory.
PMID: 31858908 [PubMed - as supplied by publisher]
Source: Current Radiopharmaceuticals - Category: Radiology Tags: Curr Radiopharm Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Immunotherapy | Lung Cancer | Melanoma | Radiology | Skin Cancer